NIH-funded research R01 grant

Hyaluronan in the limbal stem cell niche and its role in preserving eye surface stem cells

Official title: Hyaluronan in the limbal stem cell niche: from regulation of stem cell fate to translational applications

Funded at University of Houston · NIH-11378259 · Data updated 2026-11-12

This NIH grant studies how a sugar molecule called hyaluronan helps keep stem cells in the eye’s surface healthy, with an eye toward new ways to treat corneal problems.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Houston
NIH-funded
Lab location1 site (Houston, United States)
Project startSeptember 1, 2018
Project endJuly 31, 2029
Funding year2026
Award (this year)$481,946
NIH project number5R01EY029289-07
Project IDNIH-11378259 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates would be patients with corneal surface disorders where limbal stem cell function is compromised.

Less likely to help

Patients with non-ocular conditions or advanced, irreversible corneal damage may not benefit from this research.

What this research studies

Researchers are investigating how the environment around limbal stem cells in the eye uses hyaluronan to maintain stem cell properties. They will look at whether special HA-rich clusters contain progenitor-like cells that could revert to true stem cells, potentially slowing or reversing damage that leads to vision loss. The project also tests whether specific HA complexes and receptors CD44 or RHAMM are key to keeping these stem cells in a healthy state. By understanding these mechanisms, scientists hope to translate findings into better strategies for preserving or restoring the corneal surface.

Why it matters

Potential benefit: If successful, the work could lead to new treatments that protect or restore vision by maintaining or replenishing healthy corneal stem cells.

How similar studies have gone: Prior work suggests HA-rich matrices influence stem cell behavior, supporting potential translational progress for eye surface regeneration.

Where this research is happening

  • University of Houston
    Houston, United States
    Active

Researchers

  • Principal investigator: Coulson-Thomas, Vivien Jane — University of Houston
  • Study coordinator: Coulson-Thomas, Vivien Jane

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.